Are small interfering RNAs the future for lipid reduction?

One therapy being tested may only require two injections a year, say UK researchers

Two injections of a small interfering RNA (siRNA) reduce LDL-cholesterol levels in most patients, and the effect can last for nine months, a follow-up study of a clinical trial has shown.